Welcome to Genzyme Fabrazyme

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript.
You may experience difficulties browsing certain parts of the site.

Genzyme Corporate

Genzyme Websites


	This website is intended for use in the United States. Please visit the Genzyme website for your country or region.

	Fabrazyme Site Index
	A Administration of Fabrazyme Adolescent Symptoms Adult Symptoms Adverse Events Alpha-galactosidase A Angiokeratomas in Fabry Disease Antibody Formation Atypical Variants C Childhood Symptoms Clinical Studies of Fabrazyme Compliance D Diagnosing Fabry Disease Diagnostic Testing E Effects of Fabry Disease Enzyme Replacement Therapy F Fabrazyme Fabry Disease Fabry Disease Symptoms Fabry Disease Testing Fabry Disease Treatment Fabry Publications Fabry Registry/a> Facts About Fabry Female Heterozygotes G Genetic Factors of Fabry Disease	H History of Fabry Disease I Infusion Rate Infusion Scheduler Insurance Reimbursement L Living with Fabry Disease LysoSolutions M Manufacturing Process Monitoring Fabry Patients P Patient Support Networks Precautions Prescribing Information for Fabrazyme R Recommended Dosage Renal Capillary Endothelium Reseach and Development S Safety Profile Side Effects Support Resources Symptom Management T Testing for Fabry Disease

Terms and Conditions of Use | Privacy Policy | © 2003-2005 Genzyme Corporation. All rights reserved. | Fabr/US/P133/09/04